Aloxi web

What attracted you to the nursing profession?

When oncology nurses are asked this question, they often talk about the chance to make a positive difference in the lives of their patients. A nurse's special brand of caring extends beyond clinical healing and often involves their patients' quality of life.

Chemotherapy-induced nausea and vomiting (CINV)—both acute and delayed —can be a major quality-of-life issue for cancer patients. Because CINV can prevent them from living the life they want and from enjoying the people in their lives.

Like you, ALOXI^® is about making a positive difference in the lives of your patients. You make a great team.

ALOXI (palonosetron HCl) injection 0.25 mg is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy, and acute nausea and vomiting associated with initial and repeat courses of highly emetogenic chemotherapy.

ALOXI is contraindicated in patients known to have hypersensitivity to the drug or any of its components. It should be administered with caution in patients who have or may develop prolongation of cardiac conduction intervals, particularly QTc. Most commonly reported adverse reactions include headache (9%) and constipation (5%).

ALOXI is available by prescription only. Please see the important product information for ALOXI for more information.

This site does not contain everything that is known about ALOXI. If you would like to know more, talk to your healthcare professional.